Karen L Rascati, RPh, PhD
Founding Member, ISPOR-The Professional Society for Health Economics and Outcomes Research
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 273-6268
Business Email:
krascati@ufl.edu
About Karen L Rascati
Additional Positions:
Founding Member
1995 – Current
·
ISPOR-The Professional Society for Health Economics and Outcomes Research
Teaching Profile
Courses Taught
2012-2025
PHA6283 Introduction to Pharmacoeconomics
2013
PHA6287 Pharmaceutical Health Economics
2021-2024
PHA6935 Selected Topics in Pharmacy
Publications
Academic Articles
2024
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model.
Clinical drug investigation.
44(3):209-217
[DOI] 10.1007/s40261-024-01345-3.
[PMID] 38381352.
2024
Exploring factors related to clinically advanced fibrosis in patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.
Postgraduate medicine.
136(1):14-21
[DOI] 10.1080/00325481.2023.2288560.
[PMID] 38032542.
2024
Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data.
Current medical research and opinion.
40(5):781-788
[DOI] 10.1080/03007995.2024.2328653.
[PMID] 38465414.
2023
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis.
Breast cancer (Tokyo, Japan).
30(3):489-496
[DOI] 10.1007/s12282-023-01441-w.
[PMID] 36842097.
2023
Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease.
American journal of hematology.
98(1):90-101
[DOI] 10.1002/ajh.26765.
[PMID] 36251408.
2022
Economic Burden of Chronic Comorbidities Among Community-Dwelling Older Adults With Dementia: A Propensity Score Matched National-Level Study.
Alzheimer disease and associated disorders.
36(3):244-252
[DOI] 10.1097/WAD.0000000000000504.
[PMID] 35293380.
2022
General versus disease-specific health literacy in patients with breast cancer: a cross-sectional study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
30(6):5533-5538
[DOI] 10.1007/s00520-022-06988-6.
[PMID] 35316403.
2022
Healthcare Fraud Data Mining Methods: A Look Back and Look Ahead.
Perspectives in health information management.
19(1)
[PMID] 35440932.
2022
Healthcare utilization and costs among patients with chronic migraine, episodic migraine, and tension-type headache enrolled in commercial insurance plans.
Headache.
62(2):141-158
[DOI] 10.1111/head.14247.
[PMID] 35156215.
2022
Healthcare Utilization, Costs, and Adverse Events of Real-Time Continuous Glucose Monitoring versus Traditional Blood Glucose Monitoring Among US Adults with Type 1 Diabetes.
Journal of diabetes science and technology.
16(6):1393-1400
[DOI] 10.1177/19322968211031519.
[PMID] 34388953.
2022
Improving Asthma Management: Patient-Pharmacist Partnership Program in Enhancing Therapy Adherence.
Pharmacy (Basel, Switzerland).
10(1)
[DOI] 10.3390/pharmacy10010034.
[PMID] 35202083.
2022
Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010-2017.
Breast cancer research and treatment.
193(3):695-705
[DOI] 10.1007/s10549-022-06604-5.
[PMID] 35449473.
2022
Real-world opioid use among patients with migraine enrolled in US commercial insurance and risk factors associated with migraine progression.
Journal of managed care & specialty pharmacy.
28(11):1272-1281
[DOI] 10.18553/jmcp.2022.28.11.1272.
[PMID] 36282930.
2021
A network meta-analysis of efficacy and safety of first-line and second-line therapies for the management of metastatic renal cell carcinoma.
Journal of clinical pharmacy and therapeutics.
46(1):35-49
[DOI] 10.1111/jcpt.13282.
[PMID] 33112003.
2021
Age-related prescription medication utilization for the -management of sickle cell disease among Texas Medicaid patients.
Journal of opioid management.
17(4):301-310
[DOI] 10.5055/jom.2021.0662.
[PMID] 34533824.
2021
Antibiotic Utilization and Efficacy Associated With Treating Pediatric Urinary Tract Infections in Texas Medicaid Patients in the First Year of Life.
The Pediatric infectious disease journal.
40(11):993-996
[DOI] 10.1097/INF.0000000000003272.
[PMID] 34321440.
2021
Are Health Literacy and Patient Activation Related to Health Outcomes in Breast Cancer Patients?
Health literacy research and practice.
5(3):e171-e178
[DOI] 10.3928/24748307-20210524-02.
[PMID] 34260317.
2021
Association between multiple sclerosis disease severity and adherence to disease-modifying therapies.
Journal of managed care & specialty pharmacy.
27(7):915-923
[DOI] 10.18553/jmcp.2021.27.7.915.
[PMID] 34185555.
2021
Barriers to implementing pharmacoeconomics: interview study.
Expert review of pharmacoeconomics & outcomes research.
21(1):93-104
[DOI] 10.1080/14737167.2020.1766969.
[PMID] 32394752.
2021
Examination of Barriers to Medication Adherence, Asthma Management, and Control Among Community Pharmacy Patients With Asthma.
Journal of pharmacy practice.
34(4):515-522
[DOI] 10.1177/0897190019840117.
[PMID] 30947599.
2021
Impact of emergency department opioid use on future health resource utilization among patients with migraine.
Headache.
61(2):287-299
[DOI] 10.1111/head.14071.
[PMID] 33599982.
2021
Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
Clinical drug investigation.
41(3):245-253
[DOI] 10.1007/s40261-021-01009-6.
[PMID] 33580482.
2021
Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries.
Current medical research and opinion.
37(8):1315-1322
[DOI] 10.1080/03007995.2021.1923469.
[PMID] 33910428.
2021
Use of a claims-based algorithm to estimate disease severity in the multiple sclerosis Medicare population.
Multiple sclerosis and related disorders.
49
[DOI] 10.1016/j.msard.2021.102741.
[PMID] 33476882.
2021
Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention.
Current medical research and opinion.
37(9):1667-1675
[DOI] 10.1080/03007995.2021.1933928.
[PMID] 34030550.
2020
Antihypertensive agent utilization patterns among patients with uncontrolled hypertension in the United States.
Journal of clinical hypertension (Greenwich, Conn.).
22(11):2084-2092
[DOI] 10.1111/jch.14041.
[PMID] 32951318.
2020
Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes.
Journal of managed care & specialty pharmacy.
26(11):1434-1444
[DOI] 10.18553/jmcp.2020.26.11.1434.
[PMID] 33119450.
2020
Cardiovascular Outcomes Among Patients with Type 2 Diabetes Newly Initiated on Sodium-Glucose Cotransporter-2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Other Antidiabetic Medications.
Journal of managed care & specialty pharmacy.
26(5):610-618
[DOI] 10.18553/jmcp.2020.26.5.610.
[PMID] 32347181.
2020
Patterns and predictors of opioid use among migraine patients at emergency departments: A retrospective database analysis.
Cephalalgia : an international journal of headache.
40(13):1489-1501
[DOI] 10.1177/0333102420946710.
[PMID] 32781832.
2020
Replication of a Claims-based Algorithm to Estimate Multiple Sclerosis Disease Severity in a Commercially Insured Population.
Multiple sclerosis and related disorders.
46
[DOI] 10.1016/j.msard.2020.102539.
[PMID] 33032054.
2019
A Retrospective Database Study Comparing Diabetes-Related Medication Adherence and Health Outcomes for Mail-Order Versus Community Pharmacy.
Journal of managed care & specialty pharmacy.
25(3):332-340
[DOI] 10.18553/jmcp.2019.25.3.332.
[PMID] 30816817.
2019
An online survey on burden of illness among families with post-stem cell transplant mucopolysaccharidosis type I children in the United States.
Orphanet journal of rare diseases.
14(1)
[DOI] 10.1186/s13023-019-1027-3.
[PMID] 30777108.
2019
Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension.
Journal of managed care & specialty pharmacy.
25(9):1001-1010
[DOI] 10.18553/jmcp.2019.25.9.1001.
[PMID] 31456491.
2019
Correlation of antidepressant target dose optimization and achievement of glycemic control.
The mental health clinician.
9(1):12-17
[DOI] 10.9740/mhc.2019.01.012.
[PMID] 30627498.
2019
Guidelines impact cholesterol management.
Journal of clinical lipidology.
13(3):432-442
[DOI] 10.1016/j.jacl.2019.03.002.
[PMID] 30992244.
2019
Predictors of Annual Base Salary for Health Economics, Outcomes Research, and Market Access Professionals in the Biopharmaceutical Industry.
Journal of managed care & specialty pharmacy.
25(12):1328-1333
[DOI] 10.18553/jmcp.2019.25.12.1328.
[PMID] 31778614.
2019
The Role of Physical Activity in the Association Between Smoking Status and Quality of Life.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
21(8):1065-1071
[DOI] 10.1093/ntr/nty052.
[PMID] 29554318.
2018
Comparison of a medication adherence simulation in professional pharmacy students versus undergraduate students.
Currents in pharmacy teaching & learning.
10(1):102-105
[DOI] 10.1016/j.cptl.2017.09.003.
[PMID] 29248066.
2018
Determinants of health-related quality of life in international graduate students.
Currents in pharmacy teaching & learning.
10(4):413-422
[DOI] 10.1016/j.cptl.2017.12.005.
[PMID] 29793701.
2018
Increased Fracture Risk with Furosemide Use in Children with Congenital Heart Disease.
The Journal of pediatrics.
199:92-98.e10
[DOI] 10.1016/j.jpeds.2018.03.077.
[PMID] 29753543.
2018
Patterns of antiepileptic drug use in patients with potential refractory epilepsy in Texas Medicaid.
Epilepsy & behavior : E&B.
87:108-116
[DOI] 10.1016/j.yebeh.2018.07.024.
[PMID] 30120071.
2018
Refining a Claims-based Algorithm to Estimate Biologic Medication Effectiveness and Cost per Effectively Treated Patient with Rheumatoid Arthritis.
Pharmacotherapy.
38(2):172-180
[DOI] 10.1002/phar.2066.
[PMID] 29197108.
2017
Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 Inhibitors.
Journal of managed care & specialty pharmacy.
23(3):299-306
[DOI] 10.18553/jmcp.2017.23.3.299.
[PMID] 28230454.
2017
Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”.
Drugs in R&D.
17(3):487-488
[DOI] 10.1007/s40268-017-0185-9.
[PMID] 28528515.
2017
Direct and indirect costs among patients with binge-eating disorder in the United States.
The International journal of eating disorders.
50(5):523-532
[DOI] 10.1002/eat.22631.
[PMID] 27862132.
2017
Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas.
Journal of the American Pharmacists Association : JAPhA.
57(3):375-381
[DOI] 10.1016/j.japh.2017.03.012.
[PMID] 28506398.
2017
PHARMACOECONOMIC STUDIES IN WORLD HEALTH ORGANIZATION EASTERN MEDITERRANEAN COUNTRIES: REPORTING COMPLETENESS.
International journal of technology assessment in health care.
33(2):215-221
[DOI] 10.1017/S026646231700037X.
[PMID] 28578712.
2017
Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea.
Value in health regional issues.
12:7-19
[DOI] 10.1016/j.vhri.2016.07.011.
[PMID] 28648319.
2016
Adherence to the 2013 Blood Cholesterol Guidelines in Patients With Diabetes at a PCMH: Comparison of Physician Only and Combination Physician/Pharmacist Visits.
The Diabetes educator.
42(2):228-33
[DOI] 10.1177/0145721716631431.
[PMID] 26902526.
2016
Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
Journal of managed care & specialty pharmacy.
22(1):32-7
[DOI] 10.18553/jmcp.2016.22.1.32.
[PMID] 27015049.
2016
Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
Clinical therapeutics.
38(3):646-54
[DOI] 10.1016/j.clinthera.2016.01.022.
[PMID] 26899313.
2016
Medication Adherence and Persistence in Patients with Severe Major Depressive Disorder with Psychotic Features: Antidepressant and Second-Generation Antipsychotic Therapy Versus Antidepressant Monotherapy.
Journal of managed care & specialty pharmacy.
22(5):588-96
[DOI] 10.18553/jmcp.2016.22.5.588.
[PMID] 27123919.
2016
Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission.
Journal of managed care & specialty pharmacy.
22(10):1186-93
[DOI] 10.18553/jmcp.2016.22.10.1186.
[PMID] 27668567.
2015
Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma.
Journal of managed care & specialty pharmacy.
21(12):1124-32
[DOI] 10.18553/jmcp.2015.21.12.1124.
[PMID] 26679962.
2015
Direct Medical Costs and Utilization of Health Care Services to Treat Pneumonia in the United States: An Analysis of the 2007-2011 Medical Expenditure Panel Survey.
Clinical therapeutics.
37(7):1466-1476.e1
[DOI] 10.1016/j.clinthera.2015.04.013.
[PMID] 26001310.
2015
Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
Journal of managed care & specialty pharmacy.
21(5):401-7
[DOI] 10.18553/jmcp.2015.21.5.401.
[PMID] 25943001.
2015
Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.
Journal of managed care & specialty pharmacy.
21(10):956-64
[DOI] 10.18553/jmcp.2015.21.10.956.
[PMID] 26402394.
2015
Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation.
24(5):1223-33
[DOI] 10.1007/s11136-014-0842-1.
[PMID] 25432884.
2015
Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations.
Journal of managed care & specialty pharmacy.
21(6):507-14
[DOI] 10.18553/jmcp.2015.21.6.507.
[PMID] 26011552.
2014
A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications for China.
Value in health regional issues.
3:79-86
[DOI] 10.1016/j.vhri.2014.02.010.
[PMID] 29702942.
2014
Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Journal of managed care & specialty pharmacy.
20(8):862-76
[DOI] 10.18553/jmcp.2014.20.8.862.
[PMID] 25062080.
2014
Examining Opioid-Dependent Chronic Pain Patients Experiences On Buprenorphine Maintenance Therapy In The Texas Workers Compensation System: Pilot Study – Part 2.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
17(7):A769-70
[DOI] 10.1016/j.jval.2014.08.308.
[PMID] 27202827.
2014
Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.
CNS drugs.
28(11):1047-58
[DOI] 10.1007/s40263-014-0191-1.
[PMID] 25086640.
2014
Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
Journal of managed care & specialty pharmacy.
20(9):914-9
[DOI] 10.18553/jmcp.2014.20.9.914.
[PMID] 25166290.
2014
Level of Testing for Potential Medication-Related Co-Morbidities for Patients Taking Antipsychotics.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
17(7)
[DOI] 10.1016/j.jval.2014.08.1306.
[PMID] 27201323.
2014
Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
Journal of managed care & specialty pharmacy.
20(7):657-67
[DOI] 10.18553/jmcp.2014.20.7.657.
[PMID] 24967519.
2014
Trends and issues in oncology costs.
Expert review of pharmacoeconomics & outcomes research.
14(1):35-44
[DOI] 10.1586/14737167.2014.864561.
[PMID] 24328809.
2013
Estimates of charges associated with emergency department and hospital inpatient care for opioid abuse-related events.
Journal of pain & palliative care pharmacotherapy.
27(3):206-13
[DOI] 10.3109/15360288.2013.803511.
[PMID] 23879214.
2013
Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients.
Journal of managed care pharmacy : JMCP.
19(6):468-77
[DOI] 10.18553/jmcp.2013.19.6.468.
[PMID] 23806061.
2013
Pharmacoeconomics education in US colleges and schools of pharmacy.
American journal of pharmaceutical education.
77(7)
[DOI] 10.5688/ajpe777145.
[PMID] 24052648.
2013
Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
Diabetes, obesity & metabolism.
15(10):901-5
[DOI] 10.1111/dom.12103.
[PMID] 23531154.
2013
The authors’ reply to Gow et al.: “the state of health economic research in South Africa”.
PharmacoEconomics.
31(3):255-6
[DOI] 10.1007/s40273-013-0027-8.
[PMID] 23430608.
2012
A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Clinical therapeutics.
34(3):605-13
[DOI] 10.1016/j.clinthera.2012.02.007.
[PMID] 22386828.
2012
Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
Clinical therapeutics.
34(3):712-9
[DOI] 10.1016/j.clinthera.2012.01.028.
[PMID] 22381712.
2012
Assessing the quality of pharmacoeconomic studies in India: a systematic review.
PharmacoEconomics.
30(9):749-62
[DOI] 10.2165/11590140-000000000-00000.
[PMID] 22720697.
2012
Cost-effectiveness of expanded newborn screening in Texas.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
15(5):613-21
[DOI] 10.1016/j.jval.2012.02.007.
[PMID] 22867769.
2012
Effect of social influences on pharmacists’ intention to report adverse drug events.
Journal of the American Pharmacists Association : JAPhA.
52(5):622-9
[PMID] 23023842.
2012
Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis.
The Annals of pharmacotherapy.
46(11):1453-69
[DOI] 10.1345/aph.1R041.
[PMID] 23136353.
2012
Evaluation of health care costs and utilization patterns for patients with gout.
Clinical therapeutics.
34(3):640-52
[DOI] 10.1016/j.clinthera.2012.01.020.
[PMID] 22381710.
2012
Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
Arthritis care & research.
64(9):1423-9
[DOI] 10.1002/acr.21696.
[PMID] 22508663.
2012
Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility.
Schizophrenia research.
137(1-3):137-40
[DOI] 10.1016/j.schres.2012.01.043.
[PMID] 22364675.
2012
Pharmacist reporting of serious adverse drug events to the Food and Drug Administration.
Journal of the American Pharmacists Association : JAPhA.
52(5):e109-12
[PMID] 23023857.
2012
Review of survey articles regarding medication therapy management (MTM) services/programs in the United States.
Journal of pharmacy practice.
25(4):457-70
[PMID] 22544620.
2012
The need for more evidence-based studies to justify the economic value for the provision of medication therapy management and other clinical pharmacy services.
Clinical therapeutics.
34(11):2196-9
[DOI] 10.1016/j.clinthera.2012.10.002.
[PMID] 23149006.
2012
The state of health economic research in South Africa: a systematic review.
PharmacoEconomics.
30(10):925-40
[DOI] 10.2165/11589450-000000000-00000.
[PMID] 22809450.
2012
Use of antidepressant agents and the risk of type 2 diabetes.
European journal of clinical pharmacology.
68(9):1295-302
[DOI] 10.1007/s00228-011-1168-3.
[PMID] 22120432.
2012
Use of antidepressants and the risk of type 2 diabetes mellitus: a nested case-control study.
International journal of clinical pharmacy.
34(3):432-8
[DOI] 10.1007/s11096-012-9608-4.
[PMID] 22249783.
2011
Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder.
Psychiatric services (Washington, D.C.).
62(9):1032-40
[PMID] 21885581.
2011
Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
14(8):1002-9
[DOI] 10.1016/j.jval.2011.05.043.
[PMID] 22152168.
2011
Examination of pharmacists’ intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
Research in social & administrative pharmacy : RSAP.
7(4):369-82
[DOI] 10.1016/j.sapharm.2010.09.001.
[PMID] 21272531.
2011
Influence of attitudes on pharmacists’ intention to report serious adverse drug events to the Food and Drug Administration.
British journal of clinical pharmacology.
72(1):143-52
[DOI] 10.1111/j.1365-2125.2011.03944.x.
[PMID] 21332572.
2011
Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.
Clinical therapeutics.
33(12):2016-20
[DOI] 10.1016/j.clinthera.2011.10.018.
[PMID] 22101160.
2011
Retrospective evaluation of the impact of copayment increases for specialty medications on adherence and persistence in an integrated health maintenance organization system.
Clinical therapeutics.
33(5):598-607
[DOI] 10.1016/j.clinthera.2011.04.021.
[PMID] 21665044.
2011
Texas pharmacists’ knowledge of reporting serious adverse drug events to the Food and Drug Administration.
Journal of the American Pharmacists Association : JAPhA.
51(3):397-403
[DOI] 10.1331/JAPhA.2011.10079.
[PMID] 21555292.
2010
Switching of antiepileptic drug formulations.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
15(2):64-5
[PMID] 22477795.
2010
The need for oral antidiabetic treatment adherence studies in the pediatric population.
Clinical therapeutics.
32(7):1306-7
[DOI] 10.1016/j.clinthera.2010.07.009.
[PMID] 20678678.
2010
The state of health economic evaluation research in Nigeria: a systematic review.
PharmacoEconomics.
28(7):539-53
[DOI] 10.2165/11536170-000000000-00000.
[PMID] 20550221.
2009
Development of the burden of prior authorization of psychotherapeutics (BoPAP) scale to assess the effects of prior authorization among Texas Medicaid providers.
Administration and policy in mental health.
36(4):278-87
[DOI] 10.1007/s10488-009-0220-4.
[PMID] 19350379.
2009
Effects of antiepileptic drug substitutions on epileptic events requiring acute care.
Pharmacotherapy.
29(7):769-74
[DOI] 10.1592/phco.29.7.769.
[PMID] 19558250.
2009
The need for validation studies of comorbidity adjustment instruments.
Clinical therapeutics.
31(7):1578-80
[DOI] 10.1016/j.clinthera.2009.07.013.
[PMID] 19695407.
2008
Analysis of predictive value of four risk models in Medicaid recipients with chronic obstructive pulmonary disease in Texas.
Clinical therapeutics.
30 Spec No:1051-7
[DOI] 10.1016/j.clinthera.2008.06.001.
[PMID] 18640479.
2008
Antipsychotic medication utilization trends among Texas veterans: 1997-2002.
The Annals of pharmacotherapy.
42(9):1229-38
[DOI] 10.1345/aph.1L155.
[PMID] 18682544.
2008
Effects of a psychotherapeutic drug prior authorization (PA) requirement on patients and providers: a providers’ perspective.
Administration and policy in mental health.
35(3):181-8
[PMID] 18064560.
2008
Pharmacoeconomic education in US colleges and schools of pharmacy: an update.
American journal of pharmaceutical education.
72(3)
[PMID] 18698384.
2008
The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: A review.
Current therapeutic research, clinical and experimental.
69(3):268-85
[DOI] 10.1016/j.curtheres.2008.06.005.
[PMID] 24692805.
2007
Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Clinical therapeutics.
29(6):1203-13
[PMID] 17692734.
2007
Influences of attitudes on family physicians’ willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain.
Clinical therapeutics.
29 Suppl:2589-602
[DOI] 10.1016/j.clinthera.2007.12.007.
[PMID] 18164924.
2007
Pharmacoepidemiology education in US colleges and schools of pharmacy.
American journal of pharmaceutical education.
71(4)
[PMID] 17786268.
2007
The need for pharmacoeconomic studies of pharmacy services.
Clinical therapeutics.
29(7):1488-90
[PMID] 17825700.
2006
Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program.
Medical care.
44(1):87-90
[PMID] 16365617.
2006
Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
Drug safety.
29(7):621-32
[PMID] 16808554.
2006
The $64,000 question–what is a quality-adjusted life-year worth?
Clinical therapeutics.
28(7):1042-3
[PMID] 16990082.
2005
A comparison of the risk of hospitalizations due to chronicobstructive pulmonary disease in medicaid patients with various medication regimens, including ipratropium, inhaled corticosteroids, salmeterol, or their combination.
Clinical therapeutics.
27(3):346-54
[PMID] 15878389.
2005
A descriptive analysis of asthma-related medical services and prescription utilization among recipients in a Medicaid program.
The Journal of asthma : official journal of the Association for the Care of Asthma.
42(6):447-53
[PMID] 16293539.
2005
Trends in the use of typical and atypical antipsychotics in children and adolescents.
Journal of the American Academy of Child and Adolescent Psychiatry.
44(6):548-56
[PMID] 15908837.
2004
Education in pharmacoeconomics: an international multidisciplinary view.
PharmacoEconomics.
22(3):139-47
[PMID] 14871162.
2004
Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine.
Psychiatric services (Washington, D.C.).
55(2):151-6
[PMID] 14762239.
2004
Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
92(1):40-6
[PMID] 14756463.
2003
Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia.
The Journal of clinical psychiatry.
64(6):635-9
[PMID] 12823076.
2003
Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.
PharmacoEconomics.
21(10):683-97
[PMID] 12828491.
2003
Role of ethnicity in predicting antipsychotic medication adherence.
The Annals of pharmacotherapy.
37(5):625-30
[PMID] 12708934.
2002
Cost impact of botulinum toxin use in Medicaid-enrolled children with cerebral palsy.
Journal of the Southern Orthopaedic Association.
11(2):71-9
[PMID] 12741586.
2001
Dealing with skewed data: an example using asthma-related costs of medicaid clients.
Clinical therapeutics.
23(3):481-98
[PMID] 11318082.
2000
Satisfaction with a computerized practitioner order-entry system at two military health care facilities.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
57(23):2188-95
[PMID] 11127698.
1999
A comparison of antihypertensive medication utilization before and after guideline changes using the Department of Defense Prescription Database.
The Annals of pharmacotherapy.
33(5):548-53
[PMID] 10369615.
1999
Economic analysis of carboplatin versus cisplatin in lung and ovarian cancer.
PharmacoEconomics.
16(1):43-57
[PMID] 10539121.
1999
Fax technology for collecting outcomes data in a computer database.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
56(24):2540-2
[PMID] 10613373.
1999
Meta-analyses of the effectiveness of erythropoietin for end-stage renal disease and cancer.
Clinical therapeutics.
21(9):1443-55; discussion 1427
[PMID] 10509843.
1997
Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
Clinical therapeutics.
19(6):1433-45; discussion 1424
[PMID] 9444451.
1996
Benefits of certification for pharmacy specialists.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996).
NS36(2):128-34
[PMID] 8742011.
1996
Evaluation of physician intervention letters.
Medical care.
34(8):760-6
[PMID] 8709658.
1995
Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications.
Clinical therapeutics.
17(4):786-90
[PMID] 8565041.
1995
Effect of an automated, nursing unit-based drug-dispensing device on medication errors.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
52(17):1875-9
[PMID] 8528848.
1995
Effects of Medicaid drug utilization review intervention letters.
Clinical therapeutics.
17(3):525-33; discussion 516
[PMID] 7585856.
1995
Promotion of the appropriate use of outpatient drug therapy in the Texas Medicaid Program through retrospective drug use review.
Pharmacy practice management quarterly.
15(2):57-64
[PMID] 10143599.
1994
Documenting the value of pharmacist interventions.
American pharmacy.
NS34(5):50-4
[PMID] 8037120.
1993
Consumers’ evaluation of value-added pharmacy services.
American pharmacy.
NS33(3):48-56
[PMID] 8475848.
1993
Staff pharmacists’ opinions about performance appraisals.
American journal of hospital pharmacy.
50(6):1181-5
[PMID] 8517458.
1993
Use of clozapine in Texas state mental health facilities.
American journal of hospital pharmacy.
50(8):1663-6
[PMID] 8368220.
1992
Survey of formulary system policies and procedures.
American journal of hospital pharmacy.
49(1):100-3
[PMID] 1570847.
1990
Comparison of women pharmacy and nursing students.
American pharmacy.
NS30(6):49-53
[PMID] 2368669.
1989
Evaluation of mobile cart decentralization.
Hospital pharmacy.
24(5):375-6, 378
[PMID] 10293288.
1988
Brief review of the literature on decentralized drug distribution in hospitals.
American journal of hospital pharmacy.
45(3):639-41
[PMID] 3285676.
1988
Pharmacists’ satisfaction with drug product selection legislation.
American pharmacy.
NS28(10):27-32
[PMID] 3195462.
1987
Multidimensional work sampling to evaluate the effects of computerization in an outpatient pharmacy.
American journal of hospital pharmacy.
44(9):2060-7
[PMID] 3674044.
1986
Work measurement in pharmacy research.
American journal of hospital pharmacy.
43(10):2445-52
[PMID] 3538862.
Contact Details
Phones:
- Business:
- (352) 273-6268
Emails:
- Business:
- krascati@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
1225 CENTER DR
GAINESVILLE FL 32610